Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the ...
SAN DIEGO, July 20, 2026--(BUSINESS WIRE)--On July 19th, pioneering medical technology company Xenco Medical unveiled its breakthrough XenVision technology, an AI-powered musculoskeletal intelligence ...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of ...
Scientists have announced a major milestone in synthetic biology, revealing they have successfully built a synthetic cell from scratch that can feed, grow and replicate much like a natural cell. While ...
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and Supports Targeted Final Clinical Module Submission Planned for Q2 2027 White Bear Lake, ...
The baby had congenital pulmonary airway malformation (CPAM), a rare condition in which abnormal lung tissue develops during pregnancy.
Amyloidsis, new treatment retrains cells to fight the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results